Tumor cells gene-modified to produce GM-CSF potently stimulate antitumor immune responses,
in part, by causing the growth and differentiation of dendritic cells (DC). However, GM-…

Chimeric antigen receptor T (CAR-T) cell therapy is a new pillar in cancer therapeutics;
however, its application is limited by the associated toxicities. These include cytokine release …

… Dababneh MD a , Gabrielle Chappell l , Dale Chappell MD, MBA l , Omar Ahmed PharmD
l , Reona Sakemura MD, PhD d e , Cameron Durrant MD, MBA l , Saad S. Kenderian MD d e f …

Background The pathophysiology of COVID-19 includes immune-mediated
hyperinflammation, which could potentially lead to respiratory failure and death. Granulocyte-macrophage …

Fas (Apo-1/CD95) is a cell-surface protein that is responsible for initiating a cascade of
proteases (caspases) culminating in apoptotic cell death in a variety of cell types. The function of …

BACKGROUND: Severe COVID-19 pneumonia results from a hyperinflammatory immune
response (cytokine storm, CS), characterized by GM-CSF mediated activation and trafficking of …

A recent report described the expression of Fas ligand (FasL) by melanoma cells as an
important mechanism involved in the immune evasion by tumors [M. Hahne et al., Science (…

Inhibitory myeloid cells and their cytokines play critical roles in limiting chimeric antigen
receptor T (CART) cell therapy by contributing to the development of toxicities and resistance …

CD8+ T lymphocytes that specifically recognize tumor cells can be isolated and expanded
ex vivo. While the lytic properties of these cells have been well described, their fate upon …

Background In COVID-19, high levels of granulocyte macrophage-colony stimulating factor (GM-CSF)
and inflammatory myeloid cells correlate with disease severity, cytokine storm, and …